These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34613596)
1. Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems. Blotière PO; Damase-Michel C; Weill A; Maura G Drug Saf; 2021 Dec; 44(12):1323-1339. PubMed ID: 34613596 [TBL] [Abstract][Full Text] [Related]
2. Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland. Irvine L; Flynn RW; Libby G; Crombie IK; Evans JM Drug Saf; 2010 Jul; 33(7):593-604. PubMed ID: 20553060 [TBL] [Abstract][Full Text] [Related]
3. Drug prescribing before and during pregnancy in south west France: a retrolective study. Crespin S; Bourrel R; Hurault-Delarue C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C Drug Saf; 2011 Jul; 34(7):595-604. PubMed ID: 21663335 [TBL] [Abstract][Full Text] [Related]
4. Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: A nationwide cohort study. Louchet M; Collier M; Beeker N; Mandelbrot L; Sibiude J; Chouchana L; Treluyer JM PLoS One; 2024; 19(1):e0295897. PubMed ID: 38198446 [TBL] [Abstract][Full Text] [Related]
5. Prescription of hazardous drugs during pregnancy. Malm H; Martikainen J; Klaukka T; Neuvonen PJ Drug Saf; 2004; 27(12):899-908. PubMed ID: 15366977 [TBL] [Abstract][Full Text] [Related]
6. Physician characteristics and prescription drug use during pregnancy: a population-based study. Weng SS; Chen YH; Lin CC; Keller JJ; Wang IT; Lin HC Ann Epidemiol; 2013 Feb; 23(2):54-9. PubMed ID: 23218810 [TBL] [Abstract][Full Text] [Related]
7. Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database. Araujo M; Hurault-Delarue C; Sommet A; Damase-Michel C; Benevent J; Lacroix I Therapie; 2021; 76(3):239-247. PubMed ID: 32736872 [TBL] [Abstract][Full Text] [Related]
8. Drug exposure during the periconceptional period: a study of 1793 women. Autret-Leca E; Deligne J; Leve J; Caille A; Cissoko H; Jonville-Bera AP Paediatr Drugs; 2011 Oct; 13(5):317-24. PubMed ID: 21888445 [TBL] [Abstract][Full Text] [Related]
9. Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005-2015. Donald S; Sharples K; Barson D; Horsburgh S; Parkin L Eur J Clin Pharmacol; 2020 Jun; 76(6):887-896. PubMed ID: 32248249 [TBL] [Abstract][Full Text] [Related]
10. Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample. Demailly R; Escolano S; Quantin C; Tubert-Bitter P; Ahmed I Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1126-1134. PubMed ID: 28758270 [TBL] [Abstract][Full Text] [Related]
11. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Lacroix I; Hurault C; Sarramon MF; Guitard C; Berrebi A; Grau M; Albouy-Cossard C; Bourrel R; Elefant E; Montastruc JL; Damase-Michel C Eur J Clin Pharmacol; 2009 Aug; 65(8):839-46. PubMed ID: 19365629 [TBL] [Abstract][Full Text] [Related]
12. Utilisation of teratogenic medicines before and during pregnancy in Australian women. Raichand S; Pearson SA; Zoega H; Buckley NA; Havard A Aust N Z J Obstet Gynaecol; 2020 Apr; 60(2):218-224. PubMed ID: 31397495 [TBL] [Abstract][Full Text] [Related]
13. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049 [TBL] [Abstract][Full Text] [Related]
14. Off-label prescribing during pregnancy in France: the NéHaVi cohort . Laroche ML; Blin A; Coubret A; Grau M; Roux B; Aubard Y Int J Clin Pharmacol Ther; 2020 Apr; 58(4):198-208. PubMed ID: 31933473 [TBL] [Abstract][Full Text] [Related]
15. Trends in anti-infective use during pregnancy in France between 2010 and 2019: a nationwide population-based study. Tubiana S; Sibiude J; Herlemont P; Drouin J; Picone O; Duval X; Weill A; Zureik M; Dray-Spira R Br J Clin Pharmacol; 2023 May; 89(5):1629-1639. PubMed ID: 36511832 [TBL] [Abstract][Full Text] [Related]
16. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study. Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Straus SM; Stricker BH BJOG; 2015 Jul; 122(8):1119-29. PubMed ID: 25316196 [TBL] [Abstract][Full Text] [Related]
17. [Prescribed and dispensed in the third trimester of pregnancy drugs: What practices and risks?]. Parent G; Mottet N; Mairot P; Baudier F; Carel D; Goguey M; Riethmuller D; Limat S J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):754-9. PubMed ID: 26481682 [TBL] [Abstract][Full Text] [Related]
18. Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system. Bongue B; Laroche ML; Gutton S; Colvez A; Guéguen R; Moulin JJ; Merle L Eur J Clin Pharmacol; 2011 Dec; 67(12):1291-9. PubMed ID: 21691806 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study. Dillon P; O'Brien KK; McDonnell R; Donnelly-Swift E; Galvin R; Roche A; Cronin K; Walsh DR; Schelten R; Smith S; Fahey T BMC Pregnancy Childbirth; 2015 Mar; 15():67. PubMed ID: 25884886 [TBL] [Abstract][Full Text] [Related]
20. The French Pregnancy Cohort: Medication use during pregnancy in the French population. Bérard A; Abbas-Chorfa F; Kassai B; Vial T; Nguyen KA; Sheehy O; Schott AM PLoS One; 2019; 14(7):e0219095. PubMed ID: 31314794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]